Physician profile

Emily S Cline

Family · Concord Township, OH

NPI 1770208217

$7,617.95

in general payments reported to CMS, 2019-2025

33 companies · $2,817 in 2025

The $2,817 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).

See the full distribution for Family

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,342.11

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,592.96 2023-2025
Novo Nordisk INC $1,454.35 2022-2025 Wegovy, Ozempic, Rybelsus
Astrazeneca Pharmaceuticals LP $1,133.42 2023-2025 Airsupra, Breztri, Farxiga
Amgen INC. $688.55 2022-2025 Repatha, Evenity, Repatha
Lilly USA, LLC $489.24 2022-2025 Mounjaro, Zepbound, Jardiance
Phathom Pharmaceuticals, INC. $309.91 2024-2025 Voquezna
Pfizer INC. $222.08 2023-2025
Bayer Healthcare Pharmaceuticals INC. $180.40 2022-2025
Phadia US INC. $169.56 2023-2024 Immunocap
Axsome Therapeutics, INC. $159.37 2025 Auvelity
Exact Sciences Corporation $149.03 2024-2025 Cologuard Collection Kit
E.R. Squibb & Sons, L.L.C. $96.40 2024-2025 Eliquis
Astellas Pharma US INC $92.03 2024 Veozah
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $91.55 2023-2025 Xifaxan
Corcept Therapeutics $88.29 2025 Korlym
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Xeris Pharmaceuticals, INC. $81.46 2024-2025 Gvoke Hypopen, Recorlev
Novartis Pharmaceuticals Corporation $67.25 2023-2024
Aimmune Therapeutics, INC. $61.02 2025 Zenpep
Boehringer Ingelheim Pharmaceuticals, INC. $58.80 2023-2025 Jardiance, Tradjenta
Merck Sharp & Dohme LLC $54.16 2023-2025 Vaxneuvance, Gardasil 9, Rotateq
Dynavax Technologies Corporation $50.44 2023-2024 Heplisav-B
Glaxosmithkline, LLC. $49.90 2024-2025 Trelegy Ellipta, Arexvy
Ardelyx, INC. $41.18 2025 Ibsrela
Organon LLC $34.50 2023 Renflexis, Hadlima
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $33.73 2023
Kyowa Kirin, INC. $32.78 2025
Daiichi Sankyo INC. $23.95 2024 Injectafer
Ucb, INC. $22.81 2025 Bimzelx
Teva Pharmaceuticals USA, INC. $19.66 2023
Genzyme Corporation $19.24 2023
Sandoz INC. $18.83 2023 Hyrimoz
Janssen Pharmaceuticals, INC $15.90 2023 Xarelto
Currax Pharmaceuticals LLC $15.20 2023 Contrave

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Emily S Cline

$7,617.95

in general payments reported 2019-2025

Years
2022-2025
Top company
Abbvie INC.
Context
The $2,817 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/11406767/emily-s-cline

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.